LOGO
LOGO

Gilead Sciences Inc. Q2 Profit Increases, Beats Estimates

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Gilead Sciences Inc. (GILD) announced earnings for its second quarter that Increased from the same period last year and beat the Street estimates.

The company's earnings came in at $1.960 billion, or $1.56 per share. This compares with $1.614 billion, or $1.29 per share, last year.

Excluding items, Gilead Sciences Inc. reported adjusted earnings of $2.01 per share for the period.

Analysts on average had expected the company to earn $1.96 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 1.8% to $7.082 billion from $6.954 billion last year.

Gilead Sciences Inc. earnings at a glance (GAAP) :

-Earnings: $1.960 Bln. vs. $1.614 Bln. last year.
-EPS: $1.56 vs. $1.29 last year.
-Revenue: $7.082 Bln vs. $6.954 Bln last year.

-Guidance:
Full year EPS guidance: $7.95 - $8.25
Full year revenue guidance: $28.30 - $28.70 Bln

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19